🇺🇸 FDA
Patent

US 7662397

Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 7662397 (Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/543, A61K39/12